Mark Downing
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Infection Control in Healthcare
Papers in
-
- Antibiotic Use and Resistance 14
-
- COVID-19 Clinical Research Studies 6
- Co-authors
- Bradley J. Langford (13 shared papers)Larissa M. Matukas (2 shared papers)Kevin Antoine Brown (5 shared papers)Jennie Johnstone (3 shared papers)Linda R. Taggart (3 shared papers)Elizabeth Leung (3 shared papers)Rosane A. Nisenbaum (3 shared papers)Daniel R. Beriault (2 shared papers)
- Journals
- Infection Control and Hospital Epidemiology (5 papers)Open Forum Infectious Diseases (3 papers)Journal of Clinical Microbiology (2 papers)CMAJ Open (2 papers)Med (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Mark Downing
38 papers receiving 560 citations
Peers
Comparison fields: 5 of 74
- Applied Microbiology and Biotechnology 140
- Infectious Diseases 158
- Modeling and Simulation 24
- Clinical Biochemistry 19
- Neurology 50
Countries citing papers authored by Mark Downing
This map shows the geographic impact of Mark Downing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Downing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Downing more than expected).
Fields of papers citing papers by Mark Downing
This network shows the impact of papers produced by Mark Downing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Downing. The network helps show where Mark Downing may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Downing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 75 | |
| 2 | 2016 | 59 | |
| 3 | 2022 | 58 | |
| 4 | 2019 | 55 | |
| 5 | 2022 | 47 | |
| 6 | 2023 | 36 | |
| 7 | 2022 | 23 | |
| 8 | 2020 | 22 | |
| 9 | 2011 | 18 | |
| 10 | 2015 | 15 | |
| 11 | 2024 | 15 | |
| 12 | 2017 | 13 | |
| 13 | 2023 | 13 | |
| 14 | 2020 | 12 | |
| 15 | 2018 | 11 | |
| 16 | 2019 | 10 | |
| 17 | 2021 | 10 | |
| 18 | 2020 | 9 | |
| 19 | 2015 | 8 | |
| 20 | 2021 | 8 |
About Mark Downing
Mark Downing is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Parasitology, Pharmacology and Emergency Medical Services, having authored 40 papers that have together received 584 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (14 papers), COVID-19 Clinical Research Studies (6 papers), Sepsis Diagnosis and Treatment (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Travel-related health issues (2 papers), Vector-borne infectious diseases (2 papers), Infection Control and Ventilation (2 papers) and Zoonotic diseases and public health (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (140 citations), Infectious Diseases (158 citations), Modeling and Simulation (24 citations), Clinical Biochemistry (19 citations) and Neurology (50 citations). Mark Downing has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Bradley J. Langford, Larissa M. Matukas, Kevin Antoine Brown, Jennie Johnstone, Linda R. Taggart, Elizabeth Leung, Rosane A. Nisenbaum, Daniel R. Beriault, Nick Daneman and Kevin L. Schwartz. Their work appears in journals such as Infection Control and Hospital Epidemiology, Open Forum Infectious Diseases, Journal of Clinical Microbiology, CMAJ Open and Med.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.